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Abstract
Introduction:  Several  clinical  trials  on  Goal  directed  ﬂuid  therapy  (GDFT)  were  carried  out,
many of  those  using  colloids  in  order  to  optimize  the  preload.  After  the  decision  of  European
Medicines Agency,  there  is  such  controversy  regarding  its  use,  beneﬁts,  and  possible  contribution
to renal  failure.  The  objective  of  this  systematic  review  and  meta-analysis  is  to  compare  the  use
of last-generation  colloids,  derived  from  corn,  with  crystalloids  in  GDFT  to  determine  associated
complications  and  mortality.
Methods:  A  bibliographic  research  was  carried  out  in  MEDLINE  PubMed,  EMBASE  and  Cochrane
Library,  corroborating  randomized  clinical  trials  where  crystalloids  are  compared  to  colloids  in
GDFT for  major  non-cardiac  surgery  in  adults.
Results:  One  hundred  thirty  references  were  found  and  among  those  38  were  selected  and
29 analyzed;  of  these,  six  were  included  for  systematic  review  and  meta-analysis,  including
390 patients.  It  was  observed  that  the  use  of  colloids  is  not  associated  with  the  increase  of
ith  a  tendency  to  a  higher  mortality  (RR  [95%  CI]  3.87  [1.121--13.38];complications,  but  rather  w
I2 =  0.0%;  p  =  0.635).∗ Corresponding author.
E-mails: ripo542@gmail.com, ripo542@hotmail.com (J. Ripollés).
http://dx.doi.org/10.1016/j.bjane.2014.07.018
0104-0014/© 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.
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Conclusions:  Because  of  the  limitations  of  this  meta-analysis  due  to  the  small  number  of  ran-
domized  clinical  trials  and  patients  included,  the  results  should  be  taken  cautiously,  and  the
performance  of  new  randomized  clinical  trials  is  proposed,  with  enough  statistical  power,  com-
paring balanced  and  unbalanced  colloids  to  balanced  and  unbalanced  crystalloids,  following  the
protocols of  GDFT,  considering  current  guidelines  and  suggestions  made  by  groups  of  experts.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.
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Coloides  versus  cristaloides  em  ﬂuidoterapia  guiada  por  objetivos,  revisão
sistemática  e  metanálise.  Demasiadamente  cedo  ou  demasiadamente  tarde  para
obter  conclusões
Resumo
Introduc¸ão: Foram  realizados  múltiplos  ensaios  clínicos  em  ﬂuidoterapia  guiada  por  objetivos
(FGO), sendo  muitos  deles  com  o  uso  de  coloides  para  otimizac¸ão  da  pré-carga.  Após  a  decisão
da Agencia  Europea  de  Medicamento,  existe  ainda  controvérsia  sobre  sua  utilizac¸ão,  benefícios
e possível  contribuic¸ão  para  a  falência  renal.  O  objetivo  desta  revisão  sistemática  e  metanálise
é comparar  o  uso  de  coloides  de  última  gerac¸ão,  derivados  de  milho,  com  cristaloides  em  FGO
para determinar  as  complicac¸ões  e  a  mortalidade  associadas.
Métodos:  Realizac¸ão  de  uma  busca  bibliográﬁca  em  MEDLINE  Pubmed,  EMBASE  e  Biblioteca
Cochrane  comprovando  ensaios  clínicos  aleatórios  nos  quais  se  comparam  cristaloides  com
coloides  dentro  de  FGO  para  cirurgia  não  cardíaca  de  grande  porte  em  adultos.
Resultados:  Foram  obtidas  130  referências  das  quais  se  selecionaram  38  e  29  foram  analizadas;
destas, seis  foram  incluídas  para  revisão  sistemática  e  metanálise,  incluindo  390  pacientes.
Observou-se  que  o  uso  de  coloides  não  está  associado  a  um  aumento  de  complicac¸ões  mas  sim
com uma  tendência  a  maior  mortalidade  (RR  [IC  95%]  3,87  [1,121-13,38];  I2 =  0,0%;  p  =  0,635).
Conclusões:  Devido  às  limitac¸ões  desta  metanálise  em  decorrência  do  número  escasso  de
ensaios clínicos  aleatórios  e  pacientes  incluídos,  os  resultados  devem  ser  usados  com  cautela,  e
propõe-se  a  realizac¸ão  de  novos  ensaios  clínicos  aleatórios,  com  potência  estatística  suﬁciente
naqueles  em  que  se  comparam  coloides  balanceados  e  não  balanceados  com  cristaloides  bal-
anceados  e  não  balanceados,  dentro  de  protocolos  de  FGO,  respeitando  as  indicac¸ões  atuais  e
as sugestões  emitidas  pelos  grupos  de  especialistas.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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ecently,  several  clinical  trials  have  been  published,  as
ell  as  meta-analysis1--11 in  which  it  was  demonstrated  that
he  use  of  perioperative  goal-directed  ﬂuid  therapy  (GDFT)
ecreases  post-surgical2--9,11 complications,  hospital  stay2,3
nd  mortality.1,7,8 The  GDFT  is  based  on  preload  optimiza-
ion  with  the  use  of  ﬂuids,  inotropes  and/or  vasoconstrictors
hrough  algorithms  designed  for  this  purpose,  to  achieve  a
articular  target  of  stroke  volume  (SV),  cardiac  index  or  oxy-
en  delivery.  The  ultimate  goal  of  this  optimization  is  to
void  ﬂuid  overload,  as  well  as  hypoperfusion  and  hypoxia.12
From  a  pathophysiological  point  of  view,  hemodynamic
tabilization  with  colloids  should  result  in  a  smaller  amount
f  liquid  administrated,13 and  a  shorter  time  in  which  the
atient  would  ﬁnd  him/herself  in  a  relative  position  of  hypo-
olemia  and  possible  tissue  hypoperfusion.14
After  examining  the  available  evidence,  and  based  mainly
n  3  studies,15--17 in  June  2013  the  Pharmacovigilance  Risk
u
c
tssessment  Committee  of  the  European  Medicines  Agency
oncluded  that  the  beneﬁts  of  the  use  of  colloids  (hydrox-
ethylstarches  [HES])  were  smaller  than  their  risks,18 in
he  same  way  as  the  Food  and  Drug  Administration  rec-
mmended  to  avoid  its  use  in  patients  with  sepsis  and
n  patients  with  renal  insufﬁciency  (RI).19 These  conclu-
ions  were  based  on  studies  of  patients  with  sepsis,  not
n  the  context  of  intraoperative  hemodynamic  stabilization
rom  bleeding  or  relative  hypovolemia,  and  the  possibil-
ty  of  extrapolating  the  ﬁndings  is  debatable.  Recently
illies  et  al.,20 after  performing  a  systematic  review  and
eta-analysis  in  which  colloids  were  compared  with  dif-
erent  kinds  of  liquids,  concluded  that  the  use  of  HES  did
ot  increase  mortality,  hospital  stay,  RI  or  the  need  for
xtrarenal  clearance20; however,  in  this  meta-analysis  col-
oids  are  not  compared  with  crystalloids  in  studies  which
sed  a  GDFT  algorithm  and  included  only  three  randomized
ontrolled  trials  (RCTs),  in  which  colloids  were  compared
o  crystalloids  in  noncardiac  surgery.21--23 The  objective  of
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this  systematic  review  and  meta-analysis  is  to  determine
whether  the  use  of  the  latest  generation  of  colloids  derived
from  corn  (HE  6%:  130/0.4)  for  hemodynamic  optimization
in  GDFT  reduces  postoperative  complications  and  mortality.
Material and methods
Selection  criteria
The  studies  were  searched  according  to  the  following
selection  criteria  and  according  to  the  PRISMA/CONSORT24
methodology.
1.  Participants:  adult  patients  were  included  (>18  years)
undergoing  scheduled  noncardiac  surgery.  The  studies
were  not  limited  according  to  surgical  risk.
2.  Types  of  intervention:  intraoperative  GDFT  which  com-
pares  the  use  of  crystalloids  with  colloids  derived
from  last  generation  corn  (6%  HE:  130/0.4),  deﬁning
that  as  the  hemodynamic  monitoring  that  enables  the
implementation  of  a  hemodynamic  optimization  algo-
rithm  based  on  the  use  of  liquids,  inotropes  and/or
vasopressors  to  achieve  normal  or  supernormal  hemody-
namic  values.  Pulmonary  artery  catheter-guided  GDFT
is  excluded,  as  well  as  GDFT  guided  by  transesophageal
echocardiography  or  obsolete  technology.  Those  studies
comparing  HES  with  colloid  in  stroke  volume  (SV)  opti-
mization  without  contributing  with  outcomes  deﬁned  for
this  meta-analysis  were  excluded.  It  is  limited  to  col-
loids  derived  from  low  molecular  weight  corn  (HE  6%:
130/0.4).
3.  Types  of  comparison:  those  studies  comparing  GDFT  with
colloids  to  GDFT  with  crystalloids  were  selected  for
analysis.  We  excluded  those  studies  comparing  balanced
versus  unbalanced  solutions.  Those  RCTs  comparing  a
monitoring  technology  with  another,  and  those  RCTs  com-
paring  different  types  of  hemodynamic  algorithms.
4.  Outcomes:  The  primary  outcome  is  the  postoperative
complications  and  mortality.
5.  Types  of  studies:  RCTs  in  which  intraoperatory  GDFT  is
performed  in  major  scheduled  noncardiac  surgery.
Information  sources
Different  strategies  of  search  were  used  (last  updated  in
March  2014)  to  identify  relevant  studies  that  met  the  inclu-
sion  criteria  in  EMBASE,  MEDLINE  and  Cochrane  Library.
There  was  no  restriction  regarding  publication  date.  The
search  was  limited  to  articles  published  in  English.  An  addi-
tional  manual  search  was  performed  with  the  aim  that  every
study  published  was  analyzed.
Search  itemsThe  search  was  performed  using  the  following  keywords
‘‘Fluid  Therapy’’  (Mesh)  AND  ‘‘Hydroxyethyl  Starch  Deriva-
tives’’  (Mesh)  AND  ‘‘Isotonic  Solutions’’  (Mesh).
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tudy  selection  and  data  extraction
wo  independent  researchers  assessed  each  title  and
bstract  in  order  to  rule  out  the  irrelevant  RCTs  and  identify
hose  potentially  relevant;  these  were  thoroughly  analyzed
electing  those  that  met  the  inclusion  criteria  set  out  above.
he  extraction  of  data  from  the  included  RCTs  was  carried
ut  by  two  researchers  and  any  discrepancy  required  a  new
nalysis,  as  well  as  conﬁrmation  by  a  third  investigator.
Data  extraction  included  characteristics  of  included
atients  (ASA,  age),  type  of  surgery,  type  of  hemodynamic
onitoring,  algorithm  used,  use  of  ﬂuids,  inotropes  and/or
asopressors,  and  general,  respiratory,  infectious  and  surgi-
al  complications,  transfusion  and  mortality.  Data  extraction
as  revised  by  the  authors  in  order  to  avoid  errors  in  data
ranscription.
utcomes
he  primary  outcome  of  the  study  was  overall  complications
nd  mortality.
bstract measures and analysis method
tatistical  analysis
e  used  Stata  12.0  statistical  software  to  perform  statis-
ical  analysis.  The  meta-analysis  was  performed  by  inverse
ariation  method  for  dichotomous  outcomes  and  continuous
ata,  results  are  presented  as  relative  risk  (RR)  with  95%
onﬁdence  interval  (CI  95%)  The  method  of  mean  difference
as  used  with  a  model  of  random  effects.  Forest  plots  were
onstructed  considering  p  <  0.05  as  statistically  signiﬁcant.
he  heterogeneity  of  the  studies  was  evaluated  by  statisti-
al  I2; I2 values  are  deﬁned  as  little  heterogeneous,  25--50%
oderately  heterogeneous;  and  above  50%  little  homoge-
eous.  2 test  for  heterogeneity  was  performed,  considering
tatistical  signiﬁcance  p  <  0.01.
Those  studies  where  complications  or  mortality  are  equal
o  zero  cannot  be  included  in  the  creation  of  forest  plots
or  statistical  purposes.  To  evaluate  the  agreement  in  bias
ssessment  of  the  author’s  kappa  statistics  was  used.
esults
tudy  selection
e  found  130  references  in  electronic  databases,  of  which
8  were  reviewed;  of  these,  29  RCTs  were  analyzed  and
hose  which  did  not  meet  the  inclusion  criteria  were
xcluded.  Finally  six  RCTs21,25--29 were  included.  RCTs  were
ot  found  in  manual  search.  A  total  of  390  patients  were
ncluded  in  this  meta-analysis.  In  Fig.  1  the  ﬂowchart  for
electing  articles  is  shown.iases  risk  evaluation  in  individual  studies
wo  independent  researchers  carried  out  the  quality  assess-
ent  of  RCTs  included  by  Jadad30 score;  this  scale  was  used
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Table  1  Evaluation  of  biases  risk  in  isolated  studies.
Study  Year  Random-
ization
Randomization
sequence
description
Double-
blind
Blindness
description
Missing
description
Total  Comments
Senagore
et  al.25
2009  1  1  1  0  0  3  Study  not
designed  to
detect
complications
nor  effect  of
liquid
administration
Zhang
et al.26
2012  1  1  0  0  1  3
Feldheiser
et al.21
2013  1  1  1  1  1  5  Not  designed  to
analyze
complications
Yates
et al.27
2014  1  1  1  1  1  5
Lindroos
et al.28
2014  1  1  0  0  1  3  Not  designed  to
analyze
complications
Lindroos
et al.29
2013  1  1  0  0  1  3  Not  designed  to
analyze
t
m
p
w
Co  describe  the  quality  of  the  studies  by  assessing  ﬁve  ele-
ents  of  randomization,  blindness  and  application  of  the
rotocol,  with  a  score  of  1--5;  a  high-quality  trial  is  the  one
hich  has  a  score  of  5.  This  assessment  is  shown  in  Table  1.
130
references 
92 articles
eliminated, 
nonhuman,
nonadult 
38 articles
for exhaustive
review
29 RCT for
analysis 
6 RCT for
systematic
review and
metanalysis
23 studies are
excluded since
they do not meed
inclusion criteria
9 articles
excluded: they
are not RCT
Figure  1  Flowchart  of  articles  included.
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haracteristics  of  studies  included
he  selected  articles  describe  the  results  of  those  RCTs
hat  assess  the  use  of  colloids  (6%  HE:  130/0.4,  balanced
r  unbalanced)  versus  crystalloid  (balanced  or  unbalanced)
n  intraoperative  GDFT  in  programmed  noncardiac  surgery,
hose  which  include  the  postoperative  complications  and/or
ortality  as  the  primary  outcome.  The  characteristics  of  the
CTs  included  are  shown  in  Table  2.
Of  six  RCTs  analyzed,  three  RCTs25--27 were  carried  out
n  gastrointestinal  surgery;  two  in  neurosurgery28,29 and
ne  in  gynecological  surgery.21 In  ﬁve  of  the  six  RCTs
ncluded21,25--27,29 mortality  and  complications21,25--27,29 were
escribed.  Twenty-eight  were  included  in  a  systematic
eview  and  meta-analysis  as  they  describe  decrease  in
ransfusion,  which  may  be  interpreted  as  a  complica-
ion.  Only  two  RCTs  describe  postoperative  renal  failure  as
omplication.21,27
The  GDFT  was  performed  with  two  CardioQ® in  two
CT,21,25 in  two  cases  with  Flotrac®28,29 with  LiDCO  Rapid®
n  one  case27 and  through  calculation  of  pulse  pressure  vari-
tion  in  another  case.26 The  characteristics  of  the  patients
ncluded  are  shown  in  Table  3.
The  quality  of  the  RCTs  valued  by  Jadad  score  is  shown
n  Table  2, as  well  as  RCTs  funding  included  in  the  meta-
nalysis.  Table  1  presents  the  description  of  the  possible
iases.  One  kappa  agreement  of  90%  was  found  in  the  risk
ssessment  between  the  two  researchers.
Table  4  shows  the  studies  analyzed  but  not  included  in
he  meta-analysis  because  they  did  not  meet  the  inclusion
riteria  previously  described.23,31--36 Senagore  et  al.25 com-
ared  the  standard  ﬂuid  therapy  with  GDFT  with  colloids
Voluven®, Fresenius  Kabi,  Germany)  versus  crystalloids
Colloids  versus  crystalloids  in  objective-guided  ﬂuid  therapy,  systematic  review  and  meta-analysis  285
Table  2  Characteristics  of  RCT  included.
Study  Year  Population  Intervention  Comparer  Outcomes
Senagore
et  al.25
2009  Adult
patients
Undergoing
colorectal
surgery
GDFT  through  CardioQ® based
on algorithm  of  maximization
of  SV  with  HES  (Voluven®);
n =  21
GDFT  through
CardioQ® based  on
algorithm  of
maximization  of
SV  with  Ringer
lactate;  n  =  21
Hospital  stay.
Parameters  of
recuperation  of
bowel  function.
Complications
Zhang
et al.26
2012  Adult
patients
undergoing
gastroin-
testinal
surgery
GDFT  based  on  optimization
PPV  <  10%  with  HE;  n  =  20
GDFT  based  on
optimization  of
PPV  <  10%  with
Ringer  lactate;
n =  20
Hospital  stay.
Parameters  of
recuperation  of
bowel  function.
Complications
Feldheiser
et al.21
2013  Adult
patients
undergoing
ovary
surgery
GDFT  through  CardioQ® based
on maximization  algorithm  of
SV with  balanced  HES
(Volulyte®),  vasoconstrictors
and  inotropes  for  IC  >  2.5;
n =  24
GDFT  through
CardioQ® based  on
maximization
algorithm  of  SV
with  balanced
crystalloids
(Jonosteril®),
vasoconstrictors
and  inotropes  for
CI  >  2.5;  n  =  24
Total  ﬂuids
administered
intraoperatively.
Catecholamines
administered.
Hospital  stay.
Complications
Yates
et al.27
2014  Adult
patients
undergoing
colorectal
surgery
GDFT  through  LiDCO  Rapid®
based  on  algorithm  of
optimization  of  SVV  (SVV  <  10%)
with  HES  and  dopexamine;
n =  104
GDFT  through
LiDCO  Rapid®
based  on
algorithm  of
optimization  of
SVV  (SVV  <  10%)
with  Ringer
lactate  and
dopexamine;
n =  98
Gastrointestinal
complications  on
day  5.
Postoperative
complications.
Hospital  stay.
Analytical
parameters  of
coagulation
Lindroos
et al.28
2014  Adult
patients
undergoing
prone  neu-
rosurgery
GDFT  through  Flotrac® based
on algorithm  of  maximization
of  SV  with  HES;  n  =  15
GDFT  through
Flotrac® based  on
algorithm  of
maximization  of
SV  with  Ringer
acetate;  n  =  15
Fluids  necessary
for  hemodynamic
stabilization.
Coagulation
changes
Lindroos
et al.29
2013  Adult
patients
undergoing
neuro-
surgery
GDFT  through  Flotrac® based
on algorithm  of  maximization
of  SV  with  HES  and
vasopressors;  n  =  14
GDFT  through
Flotrac® based  on
algorithm  of
maximization  of
SV  with  Ringer
acetate  and
vasopressors;
n  =  14
Fluids  necessary
for  hemodynamic
stabilization.
Coagulation
changes
Study Design  Jadad  score  Conclusions  Funds  Country
Senagore
et  al.25
Monocentric
Double-
blind
RCT
3  The  use  of  GDFT  with  CardioQ®
does  is  not  beneﬁcial  and  is
more  expensive  than
conventional.  GDFT  with
colloids  is  not  beneﬁcial
Deltex  medical  USA
Zhang
et al.26
Monocentric
RCT
3  The  use  of  GDFT  with  colloids
improves  the  parameters  of
bowel  function  and  decreases
hospital  stay
Not  declared  China
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Table  2  (  Continued  )
Study  Design  Jadadscore  Conclusions  Funds  Country
Feldheiser
et  al.21
Monocentric
Double-
blind
RCT
5  The  use  of  GDFT  with  colloids
provides  higher  hemodynamic
stability,  with  no  increase  of
risk  of  ARF,  and  decreases  FFP
transfusions
Fresenius  Kabi  Germany
Yates
et al.27
Monocentric
Double-
blind
RCT
5  The  use  of  HE  in  GDFT  does  not
provide  crystalloid-related
beneﬁts,  except  for  a  lower
balance  of  ﬂuids  in  the  ﬁrst
24 h
Fresenius  Kabi  United
Kingdom
Lindroos
et al.28
Monocentric
RCT
3  The  use  of  GDFT  with  HES
decreases  the  ﬂuids
administered.  The
administration  of  400  cc  of  HES
leads  to  changes  in
thromboelastogram
Not  declared  Finland
Lindroos
et al.29
Monocentric
RCT
3  The  use  of  GDFT  with  colloids
allows  decreasing  the
perioperative  administration  of
ﬂuids  and  water  balance
Helsinki  University  Finland
HES, 
 volu
(
r
s
pRCT, randomized clinical trial; GDFT, Goal-directed ﬂuid therapy; 
FFP, fresh frozen plasma; PPV, pulse pressure variation; SV, strokeRinger  lactate)  in  GDFT  based  on  a  SV  optimization  algo-
ithm  by  CardioQ® in  low-risk  patients  undergoing  laparo-
copic  segmental  colectomy  within  an  enhanced  recovery
rogram  (fast  track).37 In  those  cases  where  no  SV  opti-
m
w
c
o
Table  3  Characteristics  of  patients  included.
Study Year Surgery Monitoring ASA Age 
Senagore
et al.25
2009 Colorectal CardioQ® ND ND 
Zhang
et al.26
2012 Gastrointestinal Arterial I/II vs. I 52.8 vs
53.3
Feldheiser21 2013 Gynecological CardioQ® II/III vs. III 58 vs. 
Yates et al.27 2014 Colorectal LiDCO
Rapid®
II vs. II 72 vs. 
Lindroos
et al.28
2014 Neurosurgery Flotrac® II vs. II 55 vs. 
Lindroos
et al.29
2013 Neurosurgery Flotrac® III vs. III 40 vs. 
ARL, Acute Renal Lesion; SI, surgical intervention; ND, no data.
Table  4  Studies  analyzed  but  not  included  in  the  meta-analysis.
Study  N  Reason  for
Krebbel  et  al.31 40  Balanced  a
Kotake et  al.32 35  A  colloid  d
L’Hermite  et  al.33 56  Does  not  i
Dehne et  al.34 60  A  colloid  d
Godet et  al.35 65  GDFT  is  no
Guo et  al.36 42  A  colloid  d
Hung et  al.23 84  GDFT  is  no
GDFT, goal-directed ﬂuid therapy; HE, hydroxyethylstarch.hydroxyethylstarches; CI, cardiac index; ARF, acute renal failure;
me; SVV, stroke volume variation.ization  was  achieved  with  20  mL  kg−1 HE  6%,  Ringer  lactate
as  used,  not  exceeding  the  recommended  doses  and  indi-
ations.  They  found  a  signiﬁcant  decrease  in  the  amount
f  liquid  needed  to  get  the  optimal  SV  (863  ±  850  mL  vs.
SI dura-
tion
Risk Describes
mortality
Describes
ARL
Describes
complications
143 vs.
150
High Yes No Yes
. 183 vs.
190
Low Yes No Yes
52 272 vs.
242
Moderate-
High
Yes Yes Yes
70 ND Moderate-
High
Yes Yes Yes
52 169 vs.
132
High No No No
43 145 vs.
146
High Yes No Yes
 exclusion
nd  unbalanced  solutions  are  compared
ifferent  from  HE  6%:  130/0.4  is  used
nclude  complications  or  mortality  as  primary  result
ifferent  from  HE  6%:  130/0.4  is  used.  GDFT  is  not  performed
t  performed
ifferent  from  HE  6%:  130/0.4  is  used.  GDFT  is  not  performed
t  performed
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389  ±  289  mL;  p  <  0.05).  In  the  HES  group  more  complications
were  presented  though  not  signiﬁcantly,  and  there  was  only
a  deceased  patient  in  the  study,  corresponding  to  HES  group.
The  primary  outcome  of  the  study  was  to  hospital  stay;  it  is
not  designed  for  analysis  of  major  complications  and  does
not  describe  cases  of  postoperative  renal  failure  or  how  it  is
deﬁned.
Zhang  et  al.26 compared  restrictive  ﬂuid  therapy  proto-
cols  with  GDFT  with  colloids  (HE  6%:  130/0.4)  or  crystalloids
(Ringer  lactate)  in  GDFT  based  on  pulse  pressure  variation
optimization  algorithm,  in  low-risk  patients  (ASA  I-II  and
estimated  blood  loss  <500  mL)  undergoing  gastrointestinal
surgery,  including  gastrectomy  and  segmental  colectomy.
There  were  no  reports  that  the  maximum  permissible  doses
of  colloid  were  exceeded,  and  in  any  case  it  was  used  in
patients  with  RI.  They  found  a  signiﬁcant  decrease  in  the  use
of  intra-operative  vasoconstrictors,  and  a  decrease  in  recov-
ery  time  of  bowel  function  for  the  HES  group  (86.2  ±  7.2  h
vs.  95.4  ±  9.1  h;  p  <  0.001);  likewise,  a  decrease  in  hos-
pital  stay  in  the  HES  group  was  detected  (9.1  ±  1.4  vs.
11.9  ±  1.2  days;  p  <  0.001).  There  were  no  differences  in
complications  between  both  groups,  and  no  patient  died
during  the  study.
Yates  et  al.27 compared  the  use  of  colloids  (HE  6%:
130/0.4  balanced)  versus  crystalloids  in  GDFT  through  SV
optimization  and  maintenance  of  stroke  volume  variation
<10%  using  LiDCO  Rapid  in  patients  at  moderate-high  risk
undergoing  colorectal  surgery.  The  maximum  dose  used  was
HE  50  mL  kg−1 using  a  balanced  gelatin  (Geloplasma®, Frese-
nius  Kabi,  Germany)  in  cases  where  that  dose  was  exceeded.
A  HES  group  patient  and  a  patient  from  the  crystalloid  group
had  RI.  Patients  included  in  the  HES  group  received  less
intraoperative  ﬂuid,  while  patients  in  the  crystalloid  group
received  more  ﬂuids  and  demanded  higher  dose  of  gelatin
to  be  optimized.  During  surgery,  there  was  no  difference  in
the  use  of  vasopressors.  The  primary  outcome  of  this  study
was  the  intestinal  function  recovery  time,  with  no  differ-
ences  found  within  the  groups.  There  were  no  signiﬁcant
differences  in  post-operatory  complications,  nor  in  hospi-
tal  stay.  It  should  be  noted  that  four  patients  in  the  HES
group  developed  acute  RI  postoperatively,  while  only  two  of
the  crystalloid  group  had  it.  Five  patients  of  HE  group,  and
two  in  the  crystalloid  group  died.  We  analyzed  the  systemic
inﬂammatory  response  by  IL-6  analysis,  with  no  differences
between  groups.
Feldheiser  et  al.21 compared  balanced  colloids  (HE  6%:
Volulyte,  Fresenius  Kabi,  Germany)  versus  balanced  crystal-
loids  (Jonosteril,  Fresenius  Kabi,  Germany)  in  GDFT  based  on
the  optimization  of  SV  and  maintenance  of  the  cardiac  index
>2.5  mL  kg  min−1,  monitored  with  CardioQ® in  low  to  mod-
erate  risk  patients  requiring  cytoreductive  resection  ovary
surgery.  The  use  of  HES  was  limited  to  the  maximum  rec-
ommended  dose,  using  fresh  frozen  plasma,  when  it  was
exceeded.  The  use  of  HES  enabled  better  hemodynamic  sta-
bilization,  in  less  time  and  with  less  liquid,  and  a  signiﬁcant
decrease  of  fresh  frozen  plasma  units;  however,  there  were
no  signiﬁcant  differences  in  postoperative  complications,
hospital  stay  or  mortality,  although  the  study  is  not  designed
for  this  purpose,  with  the  primary  result  of  the  total  ﬂuids
administered  during  the  intraoperative  period.
Lindroos  et  al.28 compared  the  use  of  colloids  (HE
6%:  130/0.4  unbalanced)  with  balanced  crystalloid  (Ringer
t
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cetate)  in  GDFT  based  on  SV  optimization  with  ﬂuids  and
asopressors,  which  is  monitored  with  Flotrac® in  low-risk
atients  undergoing  neurosurgery  in  the  prone  position.  It
as  been  shown  that  the  need  for  administration  of  ﬂu-
ds  was  25%  higher  than  with  crystalloid  than  with  colloid
o  achieve  hemodynamic  stabilization.  There  were  no  sig-
iﬁcant  differences  in  hospital  stay  or  in  complications.  A
atient  of  the  HES  group  received  transfusion  of  red  cells
oncentrate.  No  deaths  were  reported  in  the  study.  There
ere  no  reports  that  the  maximum  permissible  doses  of  col-
oids  were  exceeded  nor  of  postoperative  RI.
In  another  RCT  in  neurosurgery,  Lindroos  et  al.29 com-
ared  the  use  of  colloids  (HE  6%:  130/0.4  unbalanced)  with
alanced  crystalloid  (Ringer  acetate)  with  the  same  GDFT
lgorithm  in  patients  undergoing  craniotomy  in  the  sitting
osition;  similarly,  they  found  a smaller  decrease  of  liq-
ids  used  for  hemodynamic  stabilization  (<34%)  with  the
se  of  colloids,  although  there  were  no  signiﬁcant  differ-
nces  found  in  postoperative  complications  or  hospital  stay;
hey  did  not  report  postoperative  RI  nor  mortality  data,  thus
ssuming  that  there  were  no  deaths.  There  is  no  report  that
aximum  permissible  doses  of  colloids  were  exceeded.
rimary outcomes
otal  complications
f  the  six  RCTs  analyzed,  only  two  describe  the  total  asso-
iated  complications.  No  differences  were  found,  nor  were
here  any  evidence  that  the  use  of  colloids  was  associated
ith  complications  (RR:  1.17;  95%  CI:  0.86--1.61)  (Fig.  2).
ortality
ortality  was  assessed  on  three  of  six  RCTs  analyzed.  We
ound  a trend  toward  increased  mortality  in  favor  of  GDFT
ith  colloids  (RR:  3.87--1.121;  95%  CI:  13--38;  I2 =  0.0%;
 =  0.635),  and  in  the  three  studies  included  a higher  mor-
ality  in  the  colloid  group  compared  to  crystalloid  group  is
stimated.  There  is  no  heterogeneity,  although  it  may  seem
o  exist  a  tendency  to  publish  positive  results  (Fig.  3).
iscussion
he  comparison  of  colloids  and  crystalloids  in  GDFT  was  per-
ormed  in  multiple  surgical  procedures  with  different  types
f  hemodynamic  monitoring,  with  different  algorithms,  and
chieving  goals  through  different  methods;  as  well  as  in
atients  with  different  surgical  risk.
The  main  results  of  this  meta-analysis  are:  (1)  There  are
o  differences  in  postoperative  complications  with  the  use
f  GDFT  with  colloids  or  crystalloids;  (2)  There  is  a  tendency
o  higher  mortality  associated  with  GDFT  with  colloids;  (3)
n  the  studies  analyzed  the  RI  is  not  determined  as  a primary
utcome  or  in  accordance  with  internationally  accepted
riteria,  so  it  is  not  possible  to  draw  conclusions  regarding
he  RI  associated  with  the  use  of  colloids.  It  is  worth  noting
hat  the  high  number  of  complications  that  are  indicated  in
he  study  by  Senagore  et  al.25 largely  correspond  to  minor
omplications  (particularly  those  in  the  HES  group  [4  vs.  20])
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Senagore et al (2009)
Feldheiser (2012)
Yates et al (2013)
Zhang et al (2012)
Lindroos et al (2013)
Overall (I  = 0.0%, P=.635)2
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nd  that  this  study  has  as  primary  outcome  hospital  stay.
t  is  not  designed  for  analysis  of  major  complications.  The
ause  of  death  in  the  HES  group  is  not  described.  The  same
ccurs  in  the  study  by  Yates  et  al.27 where  the  causes  of
eath  are  not  indicated,  and  the  RCT  is  not  designed  for  the
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Figure  3  Forest  plot.  Colloids  versuscrystalloids.  Mortality.
nalysis  of  complications;  and,  on  the  other  hand,  patients  in
he  crystalloid  group  showed  a  higher  baseline  oxygen  trans-
ortation  (554  vs.  496;  p  =  0.01),  while  four  patients  had  a
ostoperative  acute  RI  in  the  HES  group  and  only  two  in  the
rystalloid  group.
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and  unbalanced  crystalloids  within  GDFT  protocols,  in  thoseColloids  versus  crystalloids  in  objective-guided  ﬂuid  therapy
Feldheiser  et  al.21 reported  a  trend  toward  increased
mortality  (5  vs.  0;  p  =  0.051),  although  these  deaths  corre-
spond  to  tumor  progression,  and  are  not  directly  related  to
the  hemodynamic  algorithm.  RI  is  not  indicated  as  a  postop-
erative  complication.  Studies  by  Lindroos  et  al.28,29 are  not
designed  for  the  analysis  of  complications  and  it  is  assumed
that  there  is  no  publication  bias,  that  is,  no  deaths  during  the
study  or  its  follow-up.  The  results  of  this  meta-analysis  show
that  there  is  a  trend  toward  increased  mortality  with  the  use
of  GDFT  with  colloids,  although,  as  described  above,  this  is
not  directly  related  to  the  intervention,  since  a  signiﬁcant
reduction  in  complications  is  obtained.  The  maintenance  of
an  adequate  cardiac  output  could  lead  to  maintenance  of
immune  function  and  protect  the  organs  that  are  at  risk
of  intraoperative  hypoperfusion,38 particularly  in  gastroin-
testinal  surgery;  it  was  demonstrated  that  the  use  of  GDFT
with  colloids  improves  the  ﬂow  of  the  superior  mesenteric
artery  by  20%,  and  the  microcirculation  in  the  gastrointesti-
nal  mucosa39 by  up  to  40%;  thus,  a  decrease  of  complications
associated  with  the  use  of  colloids  would  be  expected;  how-
ever,  this  is  not  conﬁrmed  with  the  existing  evidence.
Moreover,  studies  in  healthy  subjects  have  shown  that
blood  ﬂow  of  the  perianastomotic  colonic  mucosa  is  similar
to  the  ﬂuid  therapy  with  colloids  or  cristalloids.40
The  basic  premise  of  the  GDFT  consists  of  ensuring  an
optimal  blood  volume;  the  association  of  restrictive  ﬂuid
therapy41 with  the  identiﬁcation  of  optimal  preload  or  of
those  patients  who  increased  their  SV  through  a  volume
load  (respondent  to  ﬂuids)  implies  relative  hypovolemia;
the  quick  correction  of  this  problem  is  essential  to  ensure
correct  tissue  perfusion.  This  a  priori  should  be  faster
with  colloids,  since,  as  demonstrated  in  healthy  patients
and  animal  models,  the  proportion  of  liquid  required  to
achieve  a  goal  of  hemodynamic  stabilization  is  1:442;  how-
ever,  this  cannot  be  conﬁrmed  by  the  data  obtained  in  this
meta-analysis  nor  can  be  demonstrated  with  recent  stud-
ies  speciﬁcally  designed  to  determine  it.33 The  association
of  RI  with  the  use  of  colloids  in  the  surgical  ﬁeld  could  not
be  demonstrated,20,43 and  in  particular  in  GDFT  it  can  be
demonstrated,  since  no  RCT  analyzed  this  as  a  primary  out-
come;  thus,  it  is  not  possible  to  draw  conclusions  with  regard
to  colloids  association  with  renal  failure  in  surgical  patients
who  underwent  GDFT.
Implications  for  investigation
Currently,  there  are  two  RCTs  in  which  GDFT  with  colloids
is  compared  with  that  with  crystalloids  in  large  abdominal
surgery,  one  in  the  USA  ‘‘Effect  of  Goal-Directed  Crystalloid
Versus  Colloid  Administration  on  Major  Postoperative  Mor-
bidity’’  (NCT01195883)  in  which  they  expect  to  analyze  1112
patients,  and  with  planned  completion  date  on  November
2014;  and  another  in  Austria,  Europe,  ‘‘Crystalloids  Versus
Colloids  During  Surgery  (CC)’’  (NCT00517127),  with  comple-
tion  expected  to  2016,  and  that  aims  to  recruit  400  patients.
Both  were  approved  before  the  resolution  of  the  Phar-
macovigilance  Risk  Assessment  Committee  and  the  Food  and
Drug  Administration.  The  completion  and  publication  of  RCT,
and  the  performance  of  future  clinical  trials  in  this  area  are
essential.
In  future  RCTs,  it  would  be  advisable  to  follow  the  sugges-
tions  provided  by  Meybohm  et  al.44 adapted  to  the  operating
i
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nvironment:  limit  the  use  of  colloids  for  initial  hemody-
amic  stabilization  in  cases  where  there  is  hypovolemia
hrough  GDTF  algorithms  in  order  to  avoid  situations  of
ypovolemia  and  hypervolemia,  considering  in  all  cases  the
aximum  permissible  doses;  and  avoid  the  administration  of
hese  in  patients  with  RI,  and  performing  adequate  patient
onitoring.
Moreover,  due  to  the  controversy  generated  by  the  Phar-
acovigilance  Risk  Assessment  Committee,  in  future  clinical
rials  the  determination  of  renal  function  will  be  neces-
ary  with  the  use  of  internationally  validated  scales  (IRA
nd  RIFLE),  because  they  allow  to  homogenize  criteria  and
easure  this  dysfunction  clinical  behavior,45,46 and  also  the
erformance  of  this  procedures  with  balanced  and  unbal-
nced  colloids,  as  this  could  be  a  determining  factor.
Thus,  more  well-designed  multicenter  studies  are  neces-
ary  with  sufﬁcient  statistical  power  to  compare  crystalloid
ersus  colloid  as  ﬂuid  therapy  in  GDFT,  according  to  the  rec-
mmendations  provided  by  Meybohm  et  al.44 adapted  for
he  surgical  environment  and  in  different  surgical  proce-
ures  that  enable  the  clariﬁcation  of  the  current  controversy
urrounding  the  use  of  colloids.
imitations
s  the  literature  search  was  limited  to  PubMed  and  EMBASE;
here  could  be  studies  that  were  not  analyzed  in  this  meta-
nalysis.
The  statistical  power  of  this  meta-analysis  to  detect  an
ffect  on  complications  and  mortality  is  very  limited  by  the
ow  rate  of  complications  and  mortality,  as  well  as  due  to
he  limited  number  of  included  studies  and  patients.
As  in  the  RCT  that  were  included  the  RI  is  not  a  primary
utcome,  conclusions  in  this  ﬁeld  cannot  be  obtained.
Due  to  the  heterogeneity  of  surgeries  in  which  the  RCTs
ere  performed,  the  data  obtained  in  this  meta-analysis
hould  be  evaluated  together  with  the  individual  analysis
f  each  RCT  included.
Thus,  the  results  of  this  meta-analysis,  and  especially
hose  which  refer  to  mortality,  should  therefore  be  taken
ith  caution.
onclusions
espite  the  major  limitations  found,  this  meta-analysis
hows  that  the  use  of  the  latest  generation  of  colloids
erived  from  corn  (6%  HE:  130/0.4)  in  the  GDFT  with  algo-
ithms  which  optimizes  the  preload  to  avoid  situations  of
elative  hypovolemia  that  could  lead  to  tissue  hypoperfusion
oes  not  increase  postoperative  complications;  however,
here  is  a  tendency  to  higher  mortality  with  the  use  of  these
egarding  the  use  of  crystalloids.  Although  there  is  a  trend  to
ncreased  mortality,  the  authors  consider  that,  given  the  low
umber  of  RCTs  and  patients  included,  this  conclusion  should
e  taken  with  caution,  and  it  is  essential  to  carry  out  new
CTs  to  conﬁrm  it,  with  sufﬁcient  statistical  power  in  those
omparing  balanced  to  unbalanced  colloids  with  balancedn  which  restrictive  ﬂuid  therapy  is  held,  and  that  include
he  use  of  vasoconstrictors  and  inotropes  in  the  active  algo-
ithm,  since  they  showed  better  results,47--51 considering
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290  
urrent  indications  and  suggestions  provided  by  the  groups
f  specialists.44 Clearly,  survival  is  the  most  important  goal,
nd  is  a  primary  result  in  RCT  that  is  extremely  difﬁcult  to
nalyze,  given  the  low  incidence  of  it  in  the  surgical  ﬁeld;
herefore,  future  RCTs  should  have  sufﬁcient  sample  size  in
rder  to  determine  the  inﬂuence  of  administered  liquid  in
t.
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